Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
AEterna Zentaris completes management team with the appointment of Chief Medical Officer
August 31st, 2007
AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, announced the filling of a key position completing the management team with the appointment of Paul Blake, M.D., as Senior Vice President and Chief Medical Officer. "The appointment of Dr. Blake is timely and critical as our foremost priority is to bring our flagship product candidate, cetrorelix, to market as a novel treatment in the BPH indication in an expeditious manner", said David J. Mazzo, Ph.D., President and Chief Executive Officer at AEterna Zentaris. "Paul brings a wealth of knowledge and is an excellent addition to our team, with over...
Source: Drug Week (2007-08-31)
|
